Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA
Background: Despite having unquestionable glucose lowering efficacy, current guidelines no more favour the uses of sulphonylureas for CV safety concern, except when cost is an issue. However, formal cardiovascular outcome trial (CVOT) is not available. Materials and methods: We performed an indirect...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publishing
2020-11-01
|
| סדרה: | Diabetes & Vascular Disease Research |
| גישה מקוונת: | https://doi.org/10.1177/1479164120973653 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|